Use of antiepileptic drugs in hepatic and renal disease.
作者： Jorge J. Asconapé
DOI: 10.1016/B978-0-7020-4086-3.00027-8
关键词:
摘要: … The effects of hepatic failure on the pharmacokinetics of rufinamide have not been studied. The drug should be used with caution in patients with mild or moderate liver disease and …
sci-hub.se 参考文章(94)
David S. Adler, Ernst Martin, John G. Gambertogli, Thomas N. Tozer, Jean-Paul Spire, Hemodialysis of phenytoin in a uremic patient. Clinical Pharmacology & Therapeutics. ,vol. 18, pp. 65- 69 ,(1975) , 10.1002/CPT197518165
EDWARD T. ZAWADA, JEAN NAPPI, GREGORY DONE, DOUGLAS ROLLINS, Advances in the Hemodialysis Management of Phenobarbital Overdose Southern Medical Journal. ,vol. 76, pp. 6- 8 ,(1983) , 10.1097/00007611-198301000-00003
Wayne D. Hooper, Dennis K. Dubetz, Felix Bochner, Lesley M. Cotter, Gabrielle A. Smith, Mervyn J. Eadie, John H. Tyrer, Plasma protein binding of carbamazepine. Clinical Pharmacology & Therapeutics. ,vol. 17, pp. 433- 440 ,(1975) , 10.1002/CPT1975174433
I. Odar-Cederl�f, O. Borg�, Kinetics of diphenylhydantoin in uraemic patients: Consequences of decreased plasma protein binding European Journal of Clinical Pharmacology. ,vol. 7, pp. 31- 37 ,(1974) , 10.1007/BF00614387
George D. Olsen, William M. Bennett, George A. Porter, Morphine and phenytoin binding to plasma proteins in renal and hepatic failure Clinical Pharmacology & Therapeutics. ,vol. 17, pp. 677- 684 ,(1975) , 10.1002/CPT1975176677
Laurie Slack Mauro, Vincent F. Mauro, Kenneth A. Bachmann, James T. Higgins, J. Daniel Robinson, Accuracy of two equations in determining normalized phenytoin concentrations. Dicp-The annals of pharmacotherapy. ,vol. 23, pp. 64- 68 ,(1989) , 10.1177/106002808902300116
McLean Mj, Clinical pharmacokinetics of gabapentin Neurology. ,vol. 44, ,(1994)
Isabel Porto, Eunice G. John, Jonathan Heilliczer, Removal of phenobarbital during continuous cycling peritoneal dialysis in a child Pharmacotherapy. ,vol. 17, pp. 832- 835 ,(1997) , 10.1002/J.1875-9114.1997.TB03766.X
Olof Borgå, Charles Hoppel, Ingegerd Odar-Cederlöf, Mats Garle, Plasma levels and renal excretion of phenytoin and its metabolites in patients with renal failure Clinical Pharmacology & Therapeutics. ,vol. 26, pp. 306- 314 ,(1979) , 10.1002/CPT1979263306
Rubeen K. Israni, Nishaminy Kasbekar, Kevin Haynes, Jeffrey S. Berns, Use of antiepileptic drugs in patients with kidney disease. Seminars in Dialysis. ,vol. 19, pp. 408- 416 ,(2006) , 10.1111/J.1525-139X.2006.00195.X